Health
Genomics is helping us tackle the greatest health challenges of our time, driving life-saving breakthroughs and unlocking revolutionary advances in personalized medicine.
Fueled by more than two decades of investment by Genome Canada, genomics-enabled precision health tools are speeding up diagnoses and improving health outcomes and disease management for Canadians. Genomics is also playing a leading role in Canada’s response to major public health challenges, such as COVID-19—permitting vaccine development at record speed and large-scale sequencing efforts to track and understand the pandemic.
Genome Canada is charting a bold and more equitable future for healthcare in Canada as we harness the power of genomics—and create shared tools and data assets—to strengthen public health and shift from a disease-oriented healthcare system to one that is more precise, personalized, predictive, preventative and cost effective. We are also advancing a “One Health” approach (addressing the interconnectedness of people, animals, plants and their shared environment) to strengthen Canadian, and global, health security.
Genomics initiatives in health
All for One
A Pan-Canadian dialogue on the status of population cohorts in Canada
A national approach to large-scale, inclusive datasets can enable precision health to improve health outcomes and systems—driving life sciences innovation in Canada.
Generating solutions for Canada
Playlist
2:34
3:22
3:17
18:04
23:37
16:32
22:27
17:33
17:58
Genomics and the human health sector
The Promise of Precision Health: Sienna’s Story
“A family curse” warded off by Canadian genomics research
Coronavirus: Canada’s Research and Response | Dr. Rob Annan
Featuring Dr. Rob Annan, President and CEO, Genome Canada. In partnership with The Future Economy and part of a six-part series called The COVID-19 Rebound. (March 23, 2020)COVID-19 Point-of-Care Testing & Canada’s Ongoing Research Priorities
Featuring Dr. Dylan Pillai, Professor of Pathology and Laboratory Medicine, Medicine, and Microbiology, Immunology & Infectious Diseases at the University of Calgary, and funded through Genome Alberta. In partnership with The Future Economy and part of a six-part series called The COVID-19 Rebound. (April 20, 2020)
COVID-19 Research: Genomics, Collaboration and Funding
Featuring Dr. Natalie Prystajecky, Program Head, Environmental Microbiology & Molecular and Microbial Genomics Programs – BC Centre for Disease Control, and funded through Genome British Columbia. In partnership with The Future Economy and part of a six-part series called The COVID-19 Rebound. (April 21, 2020)
COVID-19 Research: Genomics, Rapid Execution & Funding
Featuring Dr. Samira Mubareka, Professor & Expert in Medical Microbiology and Infectious Diseases, and funded through Ontario Genomics. In partnership with The Future Economy and part of a six-part series called The COVID-19 Rebound. (April 27, 2020)COVID-19 Research: Vaccines, Genomics & Open Science
Featuring Dr. Aled Edwards, Chief Executive, Structural Genomics Consortium, and funded through Ontario Genomics and Genome Quebec. In partnership with The Future Economy and part of a six-part series called The COVID-19 Rebound. (April 28, 2020)
Canadian COVID-19 Vaccine Research Update
Covid-19 Rebound Series on how Canada’s economy is faring suring the crisis. This time we asked Dr. Volker Gerdts about Canadian vaccine research, why we should be aiming for self-sufficiency and how vaccines are being developed so much quicker than usual. The COVID-19 Rebound. (June 15, 2020)
